Bone turnover biomarkers reflect radiation-induced bone injuries in women with non-metastatic rectal cancer
- PMID: 39108362
- PMCID: PMC11299508
- DOI: 10.1093/jbmrpl/ziae087
Bone turnover biomarkers reflect radiation-induced bone injuries in women with non-metastatic rectal cancer
Abstract
Preoperative radiotherapy (RT) for non-metastatic rectal cancer reduces local recurrence rates but can cause pelvic insufficiency fractures. Despite the high morbidity from RT-induced skeletal injuries, predictive and preventive measures are lacking. How these injuries are reflected by bone biomarkers are largely unknown. The aim was to assess longitudinal changes in bone biomarkers and their relation to RT-related bone injuries in women with rectal cancer. This longitudinal cohort study includes 47 women with non-metastatic rectal cancer treated with surgery ± preoperative RT with or without chemotherapy. Sclerostin, bioactive sclerostin, C-terminal telopeptide cross-links of collagen type I (CTX), bone-specific alkaline phosphatase (BALP), and type I procollagen intact N-terminal propeptide (PINP) were measured at baseline, after RT, and 1 yr postoperatively. Pelvic magnetic resonance imaging was used for detection of skeletal injury. Sixteen of 36 (44%) irradiated women had radiation-induced bone injuries and were compared to 11 women (RT-) and 20 women (RT+) without bone injuries. Serum CTX, BALP, and PINP increased during the first year after RT in women with radiation-induced bone injuries. The difference in mean change of CTX (p=.037) and BALP (p=.042) was conferred by longitudinal regression analyses adjusted for serum estradiol. Serum sclerostin and bioactive sclerostin remained stable over time. Taken together, bone markers may be of interest for future research on fracture prediction or preventive measures in women susceptible to radiation-induced bone injury. Due to few measure points, the full pattern cannot be captured regarding the relation over time between bone biomarkers and skeletal injury from irradiation.
Keywords: bone injury; bone turnover markers; bone-specific alkaline phosphatase; radiotherapy; sclerostin.
© The Author(s) 2024. Published by Oxford University Press on behalf of the American Society for Bone and Mineral Research.
Conflict of interest statement
P.M., M.S., A.M., A.S.R., D.A., F.W., A.F.R., C.B., and J.S. report no conflicts of interest.
Figures

References
-
- Pellino G, Alós R, Biondo S, et al. . Trends and outcome of neoadjuvant treatment for rectal cancer: a retrospective analysis and critical assessment of a 10-year prospective national registry on behalf of the Spanish Rectal Cancer Project. Eur J Surg Oncol. 2021;47(2):276–284. 10.1016/j.ejso.2020.04.056 - DOI - PubMed
-
- Bahadoer RR, Dijkstra EA, van Etten B, et al. . Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22(1):29–42. 10.1016/S1470-2045(20)30555-6 - DOI - PubMed
LinkOut - more resources
Full Text Sources